SCF ENCYCLOPEDIA ENTRY

UTERINE ATONY

SCF-RDOS Postpartum Uterine Contractility Failure Disorders, Obstetric Hemorrhage Syndromes & Maternal Hemostatic Dysfunction Registry

Disease Classification

Obstetric Emergency / Postpartum Hemorrhage Disorder / Uterine Contractility Failure Syndrome / Maternal Critical Care Condition / Reproductive Hemostatic Disease

Master Registry Code

SCF-UA-0001

I. DEFINITION

Uterine Atony is the failure of the uterus to contract effectively following delivery, resulting in persistent bleeding from the placental implantation site and inadequate postpartum hemostasis.

Uterine atony is the most common cause of postpartum hemorrhage (PPH) worldwide and remains a leading contributor to:

• Maternal morbidity
• Maternal mortality
• Obstetric emergency interventions
• Blood transfusion requirements
• Intensive care admissions

Under normal conditions, postpartum uterine contraction compresses uterine blood vessels and terminates placental-site bleeding. Failure of this physiologic mechanism results in uncontrolled hemorrhage.

Within the Synergistic Compatibility Framework (SCF), uterine atony is modeled as a:

• Postpartum uterine contractility synchronization failure syndrome
• Maternal hemostatic shutdown disorder
• Placental-site vascular compression failure architecture
• Hemorrhagic decompensation cascade

II. CORE SCF ETIOPATHOGENIC PRINCIPLE

Central SCF Thesis

Uterine atony develops when postpartum myometrial contraction mechanisms fail to adequately constrict uterine vasculature after placental separation, leading to persistent hemorrhage, circulatory instability, and potential maternal decompensation.

This propagates through:

1. Placental delivery
2. Inadequate uterine contraction
3. Persistent vascular patency
4. Ongoing hemorrhage
5. Hemodynamic instability
6. Coagulopathic amplification
7. Maternal critical illness

III. MAJOR UTERINE ATONY REGISTRY

A. PRIMARY POSTPARTUM UTERINE ATONY

Most Common Form

Occurs:

• Immediately after delivery

Associated with:

• Acute postpartum hemorrhage

B. SECONDARY UTERINE ATONY

Occurs:

• Hours to days after delivery

Associated with:

• Delayed postpartum bleeding

C. OVERDISTENSION-ASSOCIATED UTERINE ATONY

Associated with:

• Multiple gestation
• Polyhydramnios
• Fetal macrosomia

Associated with:

• Polyhydramnios
• Large for Gestational Age

D. PROLONGED LABOR–ASSOCIATED UTERINE ATONY

Associated with:

• Myometrial fatigue
• Contractile exhaustion

Associated with:

• Obstructed Labor

E. MEDICATION-ASSOCIATED UTERINE ATONY

Associated with:

• Tocolytics
• General anesthesia
• Magnesium sulfate exposure

Associated with:

• Magnesium Sulfate

F. REFRACTORY UTERINE ATONY

Characterized by:

• Failure of first-line therapies
• Severe hemorrhage
• Surgical intervention requirement

IV. ETIOLOGIC DOMAINS

A. UTERINE OVERDISTENSION

Primary risk factor.

Occurs with:

• Multiple pregnancy
• Polyhydramnios
• Macrosomia

Produces:

• Reduced contractile efficiency

B. MYOMETRIAL FATIGUE

Associated with:

• Prolonged labor
• Prolonged oxytocin exposure

C. RETAINED PLACENTAL TISSUE

Prevents:

• Effective uterine contraction
• Complete involution

Associated with:

• Retained Products of Conception

D. ABNORMAL PLACENTATION

Includes:

• Placenta accreta spectrum
• Difficult placental separation

Associated with:

• Placenta Accreta Spectrum

E. PHARMACOLOGIC INHIBITION

Includes:

• Uterine relaxants
• Anesthetic agents

F. COAGULATION DYSREGULATION

May amplify:

• Ongoing hemorrhage
• Hemostatic failure

Associated with:

• Disseminated Intravascular Coagulation

V. SCF MULTI-OMIC PATHOGENESIS

A. MYOMETRIAL CONTRACTILITY FAILURE LAYER

Produces:

• Reduced uterine tone
• Failure of vessel compression

B. VASCULAR PATENCY LAYER

Results in:

• Persistent blood flow
• Placental-site bleeding

C. HEMORRHAGIC ESCALATION LAYER

Produces:

• Rapid blood loss
• Hypovolemia

D. HEMODYNAMIC INSTABILITY LAYER

Results in:

• Hypotension
• Tachycardia
• Reduced organ perfusion

E. COAGULOPATHIC AMPLIFICATION LAYER

Produces:

• Consumptive coagulopathy
• Bleeding progression

F. MULTIORGAN STRESS LAYER

Results in:

• Shock
• Organ injury
• Maternal mortality risk

VI. SCF FAULT-TIER ARCHITECTURE

SCF fault progression models uterine atony as failure of postpartum physiologic hemostasis.

VII. MAJOR CLINICAL MANIFESTATIONS

A. HEMORRHAGIC FINDINGS

Hallmark Features

• Excessive postpartum bleeding
• Rapid blood loss
• Ongoing vaginal hemorrhage

B. UTERINE FINDINGS

Includes

• Soft uterus
• Boggy uterus
• Enlarged postpartum uterus

C. CARDIOVASCULAR FINDINGS

Includes

• Tachycardia
• Hypotension
• Dizziness
• Syncope

D. SHOCK FINDINGS

Includes

• Pallor
• Altered mental status
• Cold extremities
• Circulatory collapse

VIII. MAJOR COMPLICATIONS

Hemorrhagic

Includes

• Massive postpartum hemorrhage
• Blood transfusion requirement

Associated with:

• Maternal Hemorrhage

Hemodynamic

Includes

• Hypovolemic shock
• Organ hypoperfusion

Coagulopathic

Includes

• Disseminated intravascular coagulation
• Severe bleeding disorders

Associated with:

• Disseminated Intravascular Coagulation

Surgical

Includes

• Emergency hysterectomy
• Interventional radiology procedures

Mortality

Major cause of:

• Preventable maternal death worldwide

IX. SCF RHENOVA INTERPRETATION

Within the SCF–RHENOVA framework, uterine atony represents:

• Postpartum contractility bioenergetic variance
• Hemostatic control failure
• Maternal vascular containment collapse

Key RHENOVA Signatures

• Reduced uterine tone
• Persistent vascular patency
• Hemorrhagic amplification
• Perfusion instability
• Organ stress escalation

X. SCF DBI INTERPRETATION

Under the SCF Decentralized Biological Intelligence (DBI) framework, postpartum uterine contraction functions as a biological hemostatic control algorithm designed to terminate placental-site bleeding immediately after delivery.

Uterine atony disrupts:

• Contractility regulation systems
• Vascular closure mechanisms
• Hemostatic stabilization pathways
• Postpartum recovery programs
• Maternal survival architecture

DBI Signature

Contractility Failure → Persistent Bleeding → Hemodynamic Collapse → Maternal Critical Illness

XI. SCF PATHOGENESIS LOGIC MODEL

Reconnaissance Phase

Risk factors create uterine vulnerability.

Enumeration Phase

Postpartum contractility becomes insufficient.

Exploitation Phase

Placental-site vessels remain open.

Persistence Phase

Hemorrhage progresses.

System Failure Phase

Shock and organ dysfunction emerge.

XII. DIAGNOSTIC ARCHITECTURE

Clinical Assessment

Primary diagnosis.

Evaluate:

• Vaginal bleeding
• Uterine tone
• Vital signs
• Hemodynamic stability

Physical Examination

Key finding:

• Boggy enlarged uterus

Laboratory Evaluation

Includes:

• Complete blood count
• Coagulation studies
• Fibrinogen level
• Blood typing and crossmatch

Differential Evaluation

Assess for:

• Retained placenta
• Genital tract trauma
• Coagulopathy

Associated with:

• Retained Products of Conception

XIII. SCF PCR MODEL (PREVENTATIVE–CURATIVE–RESTORATIVE)

A. PREVENTATIVE

Active Management of Third Stage of Labor

Includes:

• Routine uterotonic administration
• Controlled cord traction
• Placental assessment

Risk Identification

Includes:

• Multiple gestation
• Polyhydramnios
• Prior postpartum hemorrhage
• Placental disorders

B. CURATIVE

Uterine Massage

First-line intervention.

Purpose:

• Stimulate uterine contraction

Uterotonic Therapy

Standard agents include:

• Oxytocin
• Methylergonovine
• Carboprost
• Misoprostol

Hemorrhage Control

Includes:

• Blood transfusion
• Massive transfusion protocols
• Hemodynamic stabilization

Surgical Management

May include:

• Bakri Balloon Tamponade
• Uterine compression sutures
• Uterine artery embolization
• Hysterectomy

C. RESTORATIVE

Maternal Recovery

Includes:

• Hemoglobin restoration
• Cardiovascular recovery
• Nutritional support

Long-Term Follow-Up

Includes:

• Future pregnancy counseling
• Hemorrhage-risk assessment
• Reproductive planning

XIV. ORIGIN-OF-DISEASE & CYTOGENESIS PROGRESSION TIMELINE

Cytogenesis Loci

Primary loci:

• Myometrium
• Placental implantation site
• Uterine vasculature
• Endometrial interface

Secondary loci:

• Coagulation system
• Cardiovascular system
• Liver
• Kidneys
• Systemic circulation

XV. API DISCOVERY & THERAPEUTIC PRIORITIES

High-Priority Therapeutic Domains

Contractility Enhancement

Targets:

• Myometrial calcium signaling
• Oxytocin receptor pathways
• Smooth-muscle activation

Hemostatic Stabilization

Targets:

• Placental-site vascular closure
• Coagulation optimization
• Hemorrhage prevention

Regenerative Uterine Recovery

Targets:

• Postpartum involution
• Endometrial repair
• Vascular remodeling

DBI-Based Discovery

Targets:

• Hemorrhage-prediction biomarkers
• Contractility-resilience signatures
• Maternal recovery intelligence networks

XVI. SCF SUMMARY

Uterine Atony = Postpartum Uterine Contractility and Hemostatic Synchronization Failure Syndrome

Within SCF:

• Uterine atony is the most common cause of postpartum hemorrhage and results from failure of the uterus to contract effectively after delivery.
• The condition leads to persistent placental-site bleeding, hemorrhagic escalation, shock, coagulopathy, and potential maternal death.
• Major risk factors include uterine overdistension, prolonged labor, retained placental tissue, placental invasion disorders, and pharmacologic uterine relaxation.
• Diagnosis is clinical and centered on excessive postpartum bleeding with a soft, boggy uterus.
• Future SCF therapeutic priorities focus on contractility enhancement, precision hemorrhage prevention, hemostatic stabilization, predictive biomarkers, and postpartum recovery optimization.